Advice to Community Oncologists Treating Chronic Myeloid Leukemia
Gabriela S. Hobbs, MD, clinical director of the Leukemia Service and assistant in medicine at Massachusetts General Hospital, shares her advice for a community oncologist treating a patient with chronic myeloid leukemia.
Gabriela S. Hobbs, MD, clinical director of the Leukemia Service and assistant in medicine at Massachusetts General Hospital, shares her advice for a community oncologist treating a patient with chronic myeloid leukemia (CML).
Hobbs says it is important to understand that while patients with CML seem fine, they are still sick and require the same amount of effort as other patients. These patients can have a near-normal life expectancy, but they still need to be monitored according to the recommendations from the NCCN or ELN Guidelines.
Epcoritamab Delivers Durable Responses in Anthracycline-Ineligible LBCL
December 12th 2024Fixed-duration, subcutaneous epcoritamab-bysp achieved durable responses with a manageable safety profile in older patients with newly diagnosed large B-cell lymphoma who are not candidates for anthracycline-based therapy.
Read More
Lower Cardiac Risks Found With Second-Generation BTK Inhibitors in B-Cell Hematologic Disorders
December 12th 2024In a meta-analysis, second-generation BTK inhibitors were linked to a significantly low incidence of atrial fibrillation, overall cardiac adverse events, and heart failure in patients with B-cell hematologic malignancies.
Read More
